- 4DX
- IPO to raise $55.8M
- 76.42M shares @ $0.73
- MC $193M
- Primary market US$19.7B spent on respiratory diagnostics across 73.5M procedures 2019
- Secondary market AUS$404M across 5.3M procedures.
- FDA approval receivedMay 2020 to use the technology in its ventilation analysis software
- TGA anticipatedapproval next year 2021
- Already have grantedand pending patents in AUS, EUR and ASIA
- Funds used formarketing, operating expenditure, product research and development, sales and distributionin the US, clinical trials, trade shows
- Commercialise lungimaging technology in the US
- Develop patented X-rayimaging platform that scans patients respiratory system to help improve theability of physicians to diagnose and manage lung diseases
- XV Technology platformdelivery via cloud-based SaaS (lower cost option and it doesn’t require capitalexpenditure to be compatible with existing hospital and clinical equipment)
- Aims to supplement orreplace existing respiratory diagnostic systems
- Planning to conduct 10clinical trials in the US
- XV Technology can bedeployed immediately, using the existing hospital and clinical infrastructurewith no capital expenditure or training required, the company noted.
- The process requiresimaging departments to electronically send an X-ray, which is taken usingexisting fluoroscopy equipment, to 4DMedical.
- Dr. Andreas Fouras (MDand CEO)
- 2012 founded
- Board:
o Bruce Rathie (non-exec of PNV and NET)
o Dr Robert Figlin (former CEO LBT and founding partner of IDX)
o More here https://4dmedical.com/team/
Trade shows looking to attend:
- American ThoracicSociety annual conference - May 14-19, 2021
- American College ofChest Physicians annual meeting - October 18-21
- Radiological Society ofNorth America meeting - Nov. 29 toDec. 5
https://*********.com.au/4dmedical-asx-ipo-commercialise-lung-imaging-technology-united-states/
https://www.medicaldevice-network.com/news/us-fda-4dmedical-lung-imaging-technology/
http://fda.einnews.com/article/517874244?lcf=DHhUJxYYvCspG0nkwrpma6-uTQdcDx1sPgpesTXntx0%3D
Research
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.5¢ |
Change
0.005(0.83%) |
Mkt cap ! $236.7M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 62.5¢ | 59.5¢ | $215.2K | 352.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2369 | 60.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
60.5¢ |
Change
0.005 ( 0.62 %) |
||||
| Open | High | Low | Volume | ||
| 60.0¢ | 62.5¢ | 59.5¢ | 66870 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| 4DX (ASX) Chart |